Advertisement

Related Videos

Amit Sanyal, MD: A Clinician’s Perspective

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement




Oct
21
Today In Oncology
Claudia Henschke, PhD, MD Finding Lung Cancer in Time
Starting Surveillance Colonoscopy After High-Risk Adenoma Removal When Is the Right Time
Evolving Strategies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
AI Model Based on Facial Image Analysis Estimates Biological Age and Mortality Risk in Patients With Cancer
Community Oncology Practices Bring Advances in Cancer Testing and Treatment Closer to Patients
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo